Digestive Diseases and Sciences

, Volume 52, Issue 5, pp 1304–1309 | Cite as

Intestinal Permeability and Antigliadin Antibody Test for Monitoring Adult Patients with Celiac Disease

  • Eduardo Garcia Vilela
  • Maria de Lourdes de Abreu Ferrari
  • Henrique Osvaldo de Gama Torres
  • Fabiana Paiva Martins
  • Eugênio Marcos Andrade Goulart
  • Agnaldo Soares Lima
  • Aloíso Sales da Cunha
Original Paper


Celiac disease causes chronic inflammation of the intestinal mucosa and reduces surface absorption; after the withdrawal of gluten from the diet, there are clinical and histologic improvements. The intestinal permeability test and serologic tests are useful for confirming the diagnosis and monitoring patients. The goal of this study is to compare the antigliadin antibody (AGA) test with the intestinal permeability test for celiac patients on a gluten-free diet. The sample consisted of 22 celiac patients who were antigliadin immunoglobulin A–positive before treatment. After 12 months on a gluten-free diet, AGA testing was repeated and the intestinal permeability test was performed. A control group was composed of 11 healthy individuals. AGA remained positive in 40.9% of celiac patients, and the mean urinary lactulose excretion was 10.27%, that of mannitol was 10.18%, and the lactulose/mannitol ratio was 1.02. In the subgroup in which antigliadin became negative (59.1%), the value for lactulose was 3.79%, that for mannitol was 11.12%, the lactulose/mannitol ratio was 0.38, and the p value was less than 0.0001, 0.66, and less than 0.0001, respectively. When the two celiac subgroups were compared with the control group, the urinary lactulose excretion and the lactulose/mannitol ratio was less in the control group, whereas urinary mannitol excretion was greater. The p values were less than 0.0001 for the three variables, suggesting persistent lesions in mucosa of both subgroups, although to a lesser degree for those that became AGA negative. It is concluded that intestinal permeability allows a more precise clinical physiopathologic correlation than antigliadin and offers more information for the monitoring of these patients.


Celiac disease/treatment Intestinal permeability Intestinal mucosa Antibodies Monitoring 


  1. 1.
    Corazza GR, Frisoni M, Treggiari EA, Valentini RA, Filipponi C, Volta U, Garban G (1993) Subclinical celiac sprue increasing occurrence and clues to its diagnosis. J Clin Gastroenterol 16:16–21PubMedCrossRefGoogle Scholar
  2. 2.
    Vilela EG, Ferrari MLA, Bambirra EA, Barbosa AJA, Filho GB, Toppa NH, Goulart EA, Cunha AS (2002) Agreement between pathologists concerning assessment of intestinal biopsies from adult celiac disease patients. Gastroenterol Int 15:1–8Google Scholar
  3. 3.
    Bjarnason I, Macpherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581PubMedCrossRefGoogle Scholar
  4. 4.
    DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC (2002) Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 34:385–396PubMedCrossRefGoogle Scholar
  5. 5.
    Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ (1994) Sensitivity of aniendomysium and antigliadin antibodies in untreated celiac disease. Am J Gastroenterol 94:888–894CrossRefGoogle Scholar
  6. 6.
    Reeves GE, Burns C, Hall ST, Gleeson M, Lemmert K, Clancy RL (2000) The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods. Pathology 32:181–185PubMedGoogle Scholar
  7. 7.
    Green PHR, Jabri B (2003) Coeliac disease. Lancet 362:383–391PubMedCrossRefGoogle Scholar
  8. 8.
    Perry I, Iqbal T, Cooper B (2001) Intestinal permeability in coeliac disease. Lancet 358:1729–1730PubMedCrossRefGoogle Scholar
  9. 9.
    Walker-Smith JA, Guandalini S, Schimitz J, Scherling DH, Visakorpi JK (1990) Revised criteria for diagnosis of coeliac disease. Arc Dis Child 65:909–911Google Scholar
  10. 10.
    Dickey W, Hughes DF, McMillan SA (2000) Reliance on serum endomysial antibody testing underestimates the true prevalence of celiac disease by one fifth. Scand J Gastroenterol 35:181–183PubMedCrossRefGoogle Scholar
  11. 11.
    Farrell RJ, Kelly CP (2002) Celiac sprue. N Engl J Med 346:180–188PubMedCrossRefGoogle Scholar
  12. 12.
    Quisel A, Gill JM, Westerberg D (2002) Guideline for diagnosis of celiac disease. Del Med J 74: 229–241PubMedGoogle Scholar
  13. 13.
    Kilander AF, Nilsson LA, Gillberg R (1987) Serum antibodies to gliadin in celiac disease after gluten withdrawal. Scand J Gastroenterol 22:29–34PubMedGoogle Scholar
  14. 14.
    Farrell RJ, Kelly CP (2001) Diagnosis of celiac sprue. Am J Gastroenterol 96:3237–3246PubMedCrossRefGoogle Scholar
  15. 15.
    Menzies IS (1974) Absorption of intact oligosaccharide in health and disease. Biochem Soc Trans 2:1042–1047Google Scholar
  16. 16.
    Codben L, Dickinson RJ, Rothwell J, Axon ATR (1978) Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J 14:1960Google Scholar
  17. 17.
    Menzies IS, Laker MF, Pounder RE, Bull J, Heyer S, Wheelen PG (1979) Abnormal intestinal permeability to sugars in villous atrophy. Lancet 24:1107–1109CrossRefGoogle Scholar
  18. 18.
    Travis S, Mensies IS (1992) Intestinal permeability: functional assessment and significance. Clin Sci 82:471–488PubMedGoogle Scholar
  19. 19.
    Hollander D (1992) The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn’s disease. Scand J Gastroenterol 27:721–726PubMedGoogle Scholar
  20. 20.
    Krugliak P, Hollander D, Schlaepfer CC, Nguyen H, Ma TY (1994) Mechanisms and sites of mannitol permeability of small and large intestine in the rat. Dig Dis Sci 39:796–801PubMedCrossRefGoogle Scholar
  21. 21.
    Madara JL, Stafford J (1989) Interferon-gamma directly affects barrier function of cultured intestinal monolayers. J Clin Invest 83:724–727PubMedCrossRefGoogle Scholar
  22. 22.
    Nash S, Stafford J, Madara JL (1988) The selective and superoxide independent disruption of intestinal epithelial tight junctions during leucocyte transmigration. Lab Invest 59:531–537PubMedGoogle Scholar
  23. 23.
    Ventura A, Magazzu G, Greco L (1999) Duration of exposure to gluten and risk for autoimmune disorders in celiac patients. Gastroenterology 117:303–310CrossRefGoogle Scholar
  24. 24.
    Hollander D (2002) Crohn’s disease, TNF-α, and the leaky gut. The chicken or the egg. Am J Gastroenterol 97:1867–1868PubMedGoogle Scholar
  25. 25.
    Vogelsang H, Schwarzenhofer M, Oberhuber G (1998) Changes in gastrointestinal permeability in celiac disease. Dig Dis 16:333–336PubMedCrossRefGoogle Scholar
  26. 26.
    Perry I, Iqbal T, Cooper B (2001) Intestinal permeability in coeliac disease. Lancet 358:1729–1730PubMedCrossRefGoogle Scholar
  27. 27.
    Bjarnasson I, Peters TJ (1983) A persistent defect in intestinal permeability in coelic disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 12:323–325CrossRefGoogle Scholar
  28. 28.
    Dieterich W, Ehnis T, Bauer M, Donner P, Voulta U, Riecken EO, Shuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801PubMedCrossRefGoogle Scholar
  29. 29.
    van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G Koning F (1998) Selective deamination by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161:1585–1588PubMedGoogle Scholar
  30. 30.
    Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Marsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4 713–717PubMedCrossRefGoogle Scholar
  31. 31.
    Sollid LM (2002) Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2:647–655PubMedCrossRefGoogle Scholar
  32. 32.
    Jensen K, Sollid LM, Scott H, Paulesen G, Kett K, Thorsby E, Lundin KE (1995) Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the celiac disease associated DQ2 heterodimer. Scand J Immunol 42:166–170PubMedCrossRefGoogle Scholar
  33. 33.
    Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE (2000) Zonulin, a newly discovered modulator of intestinal permeability and its expression in celiac disease. Lancet 355:1518–1519PubMedCrossRefGoogle Scholar
  34. 34.
    Uil JJ, Van Van Overbeek FM, Meyer JW, Mulder CJ, Heymans H (1996) Follow-up of treated celiac patients: sugar absorption test and intestinal biopsies compared. Eur J Gastroenterol Hepatol 8:219–223PubMedCrossRefGoogle Scholar
  35. 35.
    Juby LD, Dixon MF, Axon AT (1987) Abnormal intestinal permeability and jejunal morphometry. J Clin Pathol 40:714–718PubMedGoogle Scholar
  36. 36.
    Duerksen DR, Wilhelm-Boyles C, Parry DM (2005) Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci 50:785–790PubMedCrossRefGoogle Scholar
  37. 37.
    Johnston SD, Smye M, Watson RGP (2001) Intestinal permeability and morphometric recovery in celiac disease. Lancet 358:259–260PubMedCrossRefGoogle Scholar
  38. 38.
    Bjarnason I, Peters TJ (1984) In vitro determination of small permeability: demonstration of a persistent defect in patients with celiac disease. Gut 25:145–150PubMedGoogle Scholar
  39. 39.
    Werneck-Silva AL, Sipahi AM, Damião AOMC, Buchpigue CA, Iriya K, Laudanna AA (2001) Intestinal permeability in strongyloidiasis. Braz J Med Biol Res 34:353–357PubMedCrossRefGoogle Scholar
  40. 40.
    Troncon LEA, Pires CR, Kraus AO, Iazigi N (1996) Estudo da permeabilidade intestinal pelo teste do 51Cr-EDTA: utilidade clínica na detecção de alterações estruturais do epitélio do intestino delgado. Arq Gastroenterol 33:66–73PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Eduardo Garcia Vilela
    • 1
  • Maria de Lourdes de Abreu Ferrari
    • 1
  • Henrique Osvaldo de Gama Torres
    • 1
  • Fabiana Paiva Martins
    • 1
  • Eugênio Marcos Andrade Goulart
    • 1
  • Agnaldo Soares Lima
    • 1
  • Aloíso Sales da Cunha
    • 1
  1. 1.Instituto Alfa de Gastroenterologia do Hospital das Clínicas da Universidade Federal de Minas GeraisBelo HorizonteBrazil

Personalised recommendations